Concept↦Monitoring↦Monitoring↦Study Requirement
What is it? Why is it important?
Study monitoring requirements are:
- Defined by the SP-INV
- Outlined in a monitoring plan
Monitoring:
- Is performed by a site independent monitor on behalf of the SP-INV
- Findings are documented in a monitoring report to be reviewed and approved by the SP-INV of the study
- Findings are assessed and corrective and preventive measures are implemented (quality management task)
A study monitor:
- Is in most cases the main line of communication between SP-INV and study site (e.g. Site -INV, study staff)
- Is independent of the study site being monitored, including any study activities to be monitored
- Reports to the SP-INV ongoing study progress, including recorded irregularities at the study site
- Supports the study site to ensure compliance with the study protocol, ICH-GCP, and applicable Swiss law and regulations (e.g. HRA, Declaration of Helsinki, ISO 14155, ISO 20916, ISO 20387)
What do I need to do?
As a SP-INV define which Swiss law(s) is applicable to your study.
Monitoring activities are:
- Mandatory for studies conducted under the ClinO and ClinO-MD
- Possible but not mandatory for studies conducted under the HRO
When deciding to include a monitor in your study:
- Make sure you employ a qualified monitor
- Be aware that the monitor should work according to an SOP, that describes monitoring procedures, including respective staff responsibilities (e.g. how to plan, set up, and conduct study monitoring)
The SP-INV can delegate monitoring activities to a contractor/CRO/local CTU, but remains responsible for the quality of any delegated services. As agreed, the SP-INV or the delegated party is responsible to provide applicable monitoring SOPs.
Where can I get help?
Your local Research Support Centre↧ can assist you with experienced staff regarding this topic
Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch
Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch
Bern, Department of Clinical Research (DCR), dcr.unibe.ch
Geneva, Clinical Research Center (CRC), crc.hug.ch
Lausanne, Clinical Research Center (CRC), chuv.ch
St. Gallen, Clinical Trials Unit (CTU), h-och.ch
Zürich, Clinical Trials Center (CTC), usz.ch
References
ICH GCP E6(R3) – see in particular guideline
- Glossary: definition monitoring
- 3.11.4 Monitoring
ICH E8 – see in particular guideline
- 6.13 Data management – centralized monitoring
- 6.2.1 Safety monitoring
ISO 14155 Medical Device – see in particular section
- 9.2.4 Monitoring (access liable to costs)
Swiss Law
HRA – search for “good practice
ClinO – see in particular article
- Art. 5 Rules of GCP
ClinO-MD – see in particular article
- Art. 17d Review areas – safety monitoring